• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人分泌型磷脂酶A2-IIA与强效中氮茚抑制剂120-1032的晶体结构

Crystal structure of human secretory phospholipase A2-IIA complex with the potent indolizine inhibitor 120-1032.

作者信息

Kitadokoro K, Hagishita S, Sato T, Ohtani M, Miki K

机构信息

Shionogi Research Laboratories, Shionogi and Co., Ltd., Fukushima-ku, Osaka 553-0002.

出版信息

J Biochem. 1998 Apr;123(4):619-23. doi: 10.1093/oxfordjournals.jbchem.a021982.

DOI:10.1093/oxfordjournals.jbchem.a021982
PMID:9538252
Abstract

Phospholipase A2 is a key enzyme in a number of physiologically important cellular processes including inflammation and transmembrane signaling. Human secretory phospholipase A2-IIA is present at high concentrations in synovial fluid of patients with rheumatoid arthritis and in the plasma of patients with septic shock. Inhibitors of this enzyme have been suggested to be therapeutically useful non-steroidal anti-inflammatory drugs. The crystal structure of human secretory phospholipase A2-IIA bound to a novel potent indolizine inhibitor (120-1032) has been determined. The complex crystallizes in the space group P3121, with cell dimensions of a = b = 75.8 A and c = 51.3 A. The model was refined to an R-factor of 0. 183 for the intensity data collected to a resolution of 2.2 A. It was revealed that the inhibitor is located near the active site and bound to the calcium ion. Although the binding mode of the 120-1032 inhibitor to human secretory phospholipase A2-IIA is similar to that previously determined for an indole inhibitor LY311299, the specific interactions between the enzyme and the inhibitor in the present complex include the oxycarboxylate group which was introduced in this inhibitor. The oxycarboxylate group in 120-1032 is coordinated to the calcium ion and included in the water-mediated hydrogen bonding to the catalytic Asp49. In addition, the ethyl group in 120-1032 gains hydrophobic contacts with the cavity wall of the hydrophobic channel of the enzyme.

摘要

磷脂酶A2是许多生理重要细胞过程中的关键酶,包括炎症和跨膜信号传导。人分泌型磷脂酶A2-IIA在类风湿性关节炎患者的滑液和脓毒性休克患者的血浆中以高浓度存在。该酶的抑制剂已被认为是治疗有用的非甾体抗炎药。已确定人分泌型磷脂酶A2-IIA与新型强效中氮茚抑制剂(120-1032)结合的晶体结构。该复合物在空间群P3121中结晶,晶胞尺寸为a = b = 75.8 Å,c = 51.3 Å。对于收集到2.2 Å分辨率的强度数据,该模型被精修至R因子为0.183。结果显示该抑制剂位于活性位点附近并与钙离子结合。虽然120-1032抑制剂与人分泌型磷脂酶A2-IIA的结合模式与先前确定的吲哚抑制剂LY311299相似,但在当前复合物中酶与抑制剂之间的特定相互作用包括该抑制剂中引入的氧羧酸盐基团。120-1032中的氧羧酸盐基团与钙离子配位,并参与到与催化性天冬氨酸49的水介导氢键中。此外,120-1032中的乙基与酶疏水通道的腔壁形成疏水接触。

相似文献

1
Crystal structure of human secretory phospholipase A2-IIA complex with the potent indolizine inhibitor 120-1032.人分泌型磷脂酶A2-IIA与强效中氮茚抑制剂120-1032的晶体结构
J Biochem. 1998 Apr;123(4):619-23. doi: 10.1093/oxfordjournals.jbchem.a021982.
2
Specific binding of non-steroidal anti-inflammatory drugs (NSAIDs) to phospholipase A2: structure of the complex formed between phospholipase A2 and diclofenac at 2.7 A resolution.非甾体抗炎药(NSAIDs)与磷脂酶A2的特异性结合:磷脂酶A2与双氯芬酸在2.7埃分辨率下形成的复合物结构。
Acta Crystallogr D Biol Crystallogr. 2006 Apr;62(Pt 4):410-6. doi: 10.1107/S0907444906003660. Epub 2006 Mar 18.
3
First structural evidence of a specific inhibition of phospholipase A2 by alpha-tocopherol (vitamin E) and its implications in inflammation: crystal structure of the complex formed between phospholipase A2 and alpha-tocopherol at 1.8 A resolution.α-生育酚(维生素E)对磷脂酶A2的特异性抑制作用的首个结构证据及其在炎症中的意义:磷脂酶A2与α-生育酚形成的复合物在1.8埃分辨率下的晶体结构
J Mol Biol. 2002 Jul 5;320(2):215-22. doi: 10.1016/S0022-2836(02)00473-4.
4
Phospholipase A2 as a target protein for nonsteroidal anti-inflammatory drugs (NSAIDS): crystal structure of the complex formed between phospholipase A2 and oxyphenbutazone at 1.6 A resolution.磷脂酶A2作为非甾体抗炎药(NSAIDs)的靶蛋白:磷脂酶A2与羟苯丁宗形成的复合物在1.6埃分辨率下的晶体结构。
Biochemistry. 2004 Nov 23;43(46):14577-83. doi: 10.1021/bi0483561.
5
Insights into metal ion binding in phospholipases A2: ultra high-resolution crystal structures of an acidic phospholipase A2 in the Ca2+ free and bound states.
Biochimie. 2006 May;88(5):543-9. doi: 10.1016/j.biochi.2005.10.014. Epub 2005 Dec 5.
6
Crystal structures of the complexes of a group IIA phospholipase A2 with two natural anti-inflammatory agents, anisic acid, and atropine reveal a similar mode of binding.IIA族磷脂酶A2与两种天然抗炎剂(茴香酸和阿托品)形成的复合物的晶体结构揭示了相似的结合模式。
Proteins. 2006 Jul 1;64(1):89-100. doi: 10.1002/prot.20970.
7
Crystal structure of the complex of bovine pancreatic phospholipase A2 with the inhibitor 1-hexadecyl-3-(trifluoroethyl)-sn-glycero-2-phosphomethanol,牛胰磷脂酶A2与抑制剂1-十六烷基-3-(三氟乙基)-sn-甘油-2-磷酸甲醇复合物的晶体结构
Biochemistry. 1997 Nov 18;36(46):14186-91. doi: 10.1021/bi971370b.
8
Structures of free and inhibited human secretory phospholipase A2 from inflammatory exudate.
Science. 1991 Nov 15;254(5034):1007-10. doi: 10.1126/science.1948070.
9
Aspirin induces its anti-inflammatory effects through its specific binding to phospholipase A2: crystal structure of the complex formed between phospholipase A2 and aspirin at 1.9 angstroms resolution.阿司匹林通过其与磷脂酶A2的特异性结合发挥抗炎作用:磷脂酶A2与阿司匹林形成的复合物在1.9埃分辨率下的晶体结构。
J Drug Target. 2005 Feb;13(2):113-9. doi: 10.1080/10611860400024078.
10
Potent inhibitors of secretory phospholipase A2: synthesis and inhibitory activities of indolizine and indene derivatives.分泌型磷脂酶A2的强效抑制剂:中氮茚和茚衍生物的合成及抑制活性
J Med Chem. 1996 Sep 13;39(19):3636-58. doi: 10.1021/jm960395q.

引用本文的文献

1
Structural and Functional Aspects of Targeting the Secreted Human Group IIA Phospholipase A.靶向分泌型人组 IIA 磷脂酶 A 的结构与功能方面。
Molecules. 2020 Sep 28;25(19):4459. doi: 10.3390/molecules25194459.
2
Platelets release mitochondria serving as substrate for bactericidal group IIA-secreted phospholipase A2 to promote inflammation.血小板释放线粒体,作为杀菌性IIA组分泌型磷脂酶A2的底物,以促进炎症反应。
Blood. 2014 Oct 2;124(14):2173-83. doi: 10.1182/blood-2014-05-573543. Epub 2014 Jul 31.
3
Biochemical characterization of selective inhibitors of human group IIA secreted phospholipase A(2) and hyaluronic acid-linked inhibitor conjugates.
选择性人 IIA 分泌型磷脂酶 A(2)和透明质酸连接抑制剂缀合物抑制剂的生化特性。
Biochemistry. 2012 Oct 30;51(43):8617-26. doi: 10.1021/bi301140b. Epub 2012 Oct 18.
4
Highly specific and broadly potent inhibitors of mammalian secreted phospholipases A2.哺乳动物分泌型磷脂酶A2的高特异性和广泛有效的抑制剂。
J Med Chem. 2008 Aug 14;51(15):4708-14. doi: 10.1021/jm800422v. Epub 2008 Jul 8.